Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-19T06:24:23.744Z Has data issue: false hasContentIssue false

Trials of intranasally administered rubella vaccine

Published online by Cambridge University Press:  15 May 2009

Irene B. Hillary
Affiliation:
Department of Medical Microbiology, University College, Dublin
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

No evidence of vaccine virus transmission was found in two studies where Wistar RA 27/3 rubella vaccine was administered intranasally. Vaccine was immunogenic in all of 23 vaccinated children in one study, while in the other only 5 of the 11 vaccinees developed antibody. The reduced seroconversion rate in the latter study appears to have been caused by one or a combination of factors, including the vaccination technique, the presence of infective nasal conditions in vaccinees and the titre of vaccine used.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1971